Repeal of Contentious Medical Device Tax Passes in House

As expected, the “Protect Medical Innovation At” (H.R. 160) passed in the U.S. House of Representatives earlier this month. The bill would effectively repeal the medical device excise tax enacted in 2013 as part of the Patient Protection and Affordable Care Act (ACA). Proponents of the repeal contend the added cost has depressed research and development (R&D) within the device industry. Kalorama Information regularly assesses industry R&D trends by tracking related expenditures of the most representative medical device companies. The latest sixth edition of the Global Market for Medical Devices also tracks medical device tax payments from the largest medical device companies.